SEC Filing Summary: India Globalization Capital, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by India Globalization Capital, Inc. (the "Company") on January 16, 2013, reporting events occurring on January 11, 2013. The filing addresses the Company's status regarding its listing on the NYSE MKT LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding listing fees.
Material Changes
On January 11, 2013, the Company was notified by the NYSE MKT that it had resolved a continued listing deficiency under Section 1003(f)(iv) of the Company Guide. This deficiency was related to the submission of unpaid listing fees, which the Company paid by the January 10, 2013 deadline.
Guidance, Outlook, and Management Commentary
On January 14, 2013, the Company issued a press release (Exhibit 99.1) confirming it had regained compliance with the NYSE MKT listing standards. No forward-looking guidance, risk factors, or unusual items were disclosed in this specific filing.
Investor Verification Checklist
- Verify the Company's current stock listing status on the NYSE MKT.
- Review the attached press release (Exhibit 99.1) for additional details on the compliance resolution.
- Confirm that all future listing fees are current to avoid potential delisting notices.
- Note that the registrant name in the filing is India Globalization Capital, Inc., distinct from the "IGC Pharma, Inc." label in the request metadata.